Denna A. Zebda

Denna Zebda practices at UT Physicians in Houston, Texas.

Denna Zebda's NPI, 1942656723, was assigned on May 10, 2016. Denna Zebda graduated from McGovern Medical School in 2016. Denna Zebda's Texas license number on file is T2297.

Denna Zebda's primary practice is UT Physicians, at 11914 Astoria Blvd, Houston, TX 77089 in Harris County. The practice phone is (832) 325-7325.

Denna Zebda's primary practice is UT Physicians in Houston, Texas. Denna Zebda is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is UT Physicians. Dmand AI also links Denna Zebda to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Denna Zebda practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Denna Zebda's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Denna Zebda is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Denna Zebda has a license on file in Texas.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Denna Zebda treats.

CMS data shows 269 Medicare services from Denna Zebda across 7 procedure codes in 2024, for 136 Medicare patients. Medicare paid $20,413 for them. Every service was in an office.

CMS counts 136 Medicare patients who saw Denna Zebda in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Denna Zebda's median patient age at 64, with 62% women.

In 2024, Denna Zebda wrote 1,075 Medicare Part D claims for 345 patients. 98% of them were for generic drugs. CMS names the drug for 962 of them, across 14 drugs with 11 or more claims each, at $18,566 in total drug cost. In 2023, CMS named 960 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Denna Zebda for performance year 2024, reported as part of a group. Denna Zebda accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Denna Zebda, published from 2015 to 2021. 2015 was the busiest year, with 2. The most frequent topics are Clinical Competence. Denna Zebda's most frequent co-authors are Zi Yang Jiang, MD, Martin J. Citardi, MD and Amber U. Luong, MD, PhD.

CMS Open Payments shows 17 general payments to Denna Zebda from 6 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Inspire Medical Systems, Inc. paid the most, $422.

Denna Zebda graduated from McGovern Medical School in 2016.

Denna Zebda is in network with 21 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.